Andrew Godkin

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 8

Top Venues

The Journal of biological chemistry

Cancer immunology, immunotherapy : CII

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Cardiff University School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cardiff University School of Medicine Aug 01 2014

United Kingdom

Professor :: MEDIC

Publications

Martin J Scurr, George Lippiatt, Lorenzo Capitani, Kirsten Bentley, Sarah N Lauder, Kathryn Smart, Michelle S Somerville, Tara Rees, Richard James Stanton, Awen Gallimore, James P Hindley, Andrew Godkin
Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity. Nature communications 13 (1) (2022)
Martin J Scurr, Wioleta Milena Zelek, George Lippiatt, Michelle Somerville, Stephanie E A Burnell, Lorenzo Capitani, Kate Davies, Helen Lawton, Thomas Tozer, Tara Rees, Kerry Roberts, Mererid Evans, Amanda Jackson, Charlotte Young, Lucy C Fairclough, Paddy Tighe, Mark Wills, Andrew D Westwell, B Paul Morgan, Awen M Gallimore, Andrew Godkin
Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers. Immunology (2021)
Stephanie E A Burnell, Lorenzo Capitani, Bruce J MacLachlan, Georgina H Mason, Awen M Gallimore, Andrew Godkin
Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity. Immunotherapy advances 2 (1) (2021)
Rachel E Bradley, Mark James Ponsford, Martin J Scurr, Andrew Godkin, Stephen R A Jolles, null null
Persistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case Report. Journal of clinical immunology (2021)
Ana Pires, Alexander Greenshields-Watson, Emma Jones, Kathryn Smart, Sarah Nicol Lauder, Michelle Somerville, Stefan Milutinovic, Howard Kendrick, James P Hindley, Rhiannon French, Matthew John Smalley, William J Watkins, Robert Andrews, Andrew Godkin, Awen M Gallimore
Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection. Cancer immunology research 8 (12) (2020)
Martin J Scurr, Alex Greenshields-Watson, Emma Campbell, Michelle S Somerville, Yuan Chen, Sarah L Hulin-Curtis, Stephanie E A Burnell, James A Davies, Michael M Davies, Rachel Hargest, Simon Phillips, Adam D Christian, Kevin E Ashelford, Robert Andrews, Alan L Parker, Richard James Stanton, Awen Gallimore, Andrew Godkin
Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant Cells. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (13) (2020)
Bruce J MacLachlan, Garry Dolton, Athanasios Papakyriakou, Alexander Greenshields-Watson, Georgina H Mason, Andrea Schauenburg, Matthieu Besneux, Barbara Szomolay, Tim Elliott, Andrew K Sewell, Awen M Gallimore, Pierre J Rizkallah, David K Cole, Andrew Godkin
Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope. The Journal of biological chemistry 294 (52) (2019)
Matthieu Besneux, Alexander Greenshields-Watson, Martin J Scurr, Bruce J MacLachlan, Adam Christian, Michael M Davies, Rachel Hargest, Simon Phillips, Andrew Godkin, Awen M Gallimore
The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design. Cancer immunology, immunotherapy : CII 68 (2) (2018)

Andrew Godkin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew Godkin